CANSINO BIOLOGICS INC revenue for the last year amounted to 824.88 M CNY, the most of which — 800.34 M CNY — came from its highest performing source at the moment, Vaccine and Related Products. The greatest contribution to the revenue figure was made by China — last year it brought CANSINO BIOLOGICS INC 795.16 M CNY, and the year before that — 342.03 M CNY.